Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.2630
+0.0230 (9.58%)
Feb 13, 2026, 2:01 PM EST
Biotricity Revenue
Biotricity had revenue of $3.99M in the quarter ending December 31, 2025, with 10.19% growth. This brings the company's revenue in the last twelve months to $15.45M, up 16.46% year-over-year. In the fiscal year ending March 31, 2025, Biotricity had annual revenue of $13.79M with 14.32% growth.
Revenue (ttm)
15.45M
Revenue Growth
+16.46%
P/S Ratio
0.49
Revenue / Employee
335.87K
Employees
46
Market Cap
7.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 13.79M | 1.73M | 14.32% |
| Mar 31, 2024 | 12.06M | 2.42M | 25.15% |
| Mar 31, 2023 | 9.64M | 1.99M | 26.00% |
| Mar 31, 2022 | 7.65M | 4.27M | 126.02% |
| Mar 31, 2021 | 3.38M | 1.97M | 138.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADM Tronics Unlimited | 3.36M |
| Kelyniam Global | 2.67M |
| QHSLab | 2.61M |
| BioElectronics | 1.61M |
| Co-Diagnostics | 507.89K |
| CYduct Diagnostics | 344.78K |
| ALR Technologies SG | 25.54K |
| REMSleep Holdings | 6.73K |
Biotricity News
- 4 days ago - Biotricity Q3 2026 Earnings Call: Complete Transcript - Benzinga
- 4 days ago - Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Biotricity GAAP EPS of -$0.04, revenue of $4M - Seeking Alpha
- 4 days ago - Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA - GlobeNewsWire
- 5 days ago - Earnings Preview: Biotricity - Benzinga
- 10 days ago - Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th - GlobeNewsWire
- 7 weeks ago - The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - Nasdaq
- 3 months ago - Biotricity, Inc. (BTCY) Q2 2026 Earnings Call Transcript - Seeking Alpha